- Nifty Pharma soars 4.5% on exclusion from Trump’s reciprocal tariffs; Gland Pharma, Dr Reddy’s jump 10% Moneycontrol
- Big relief for India! Trump spares pharma from harsh tariffs The Economic Times
- Indian pharma’s US exposure could be a future risk, says InCred CNBC TV18
- Sun Pharma, Gland Pharma, Other Pharma Stocks In Focus After Exemption From Trump’s Tariffs News18
- Trump Tariffs Exempt Pharma, Semiconductors, Energy: GTRI Rediff MoneyWiz
Nifty Pharma soars 4.5% on exclusion from Trump’s reciprocal tariffs; Gland Pharma, Dr Reddy’s jump 10% MoneycontrolBig relief for India! Trump spares pharma from harsh tariffs The Economic TimesIndian pharma’s US exposure could be a future risk, says InCred CNBC TV18Sun Pharma, Gland Pharma, Other Pharma Stocks In Focus After Exemption From Trump’s Tariffs News18Trump Tariffs Exempt Pharma, Semiconductors, Energy: GTRI Rediff MoneyWiz Top stories – Google News